Free Trial

Pliant Therapeutics (PLRX) SEC Filings & 10K Form

Pliant Therapeutics logo
$1.46 +0.02 (+1.39%)
Closing price 04:00 PM Eastern
Extended Trading
$1.46 +0.01 (+0.34%)
As of 05:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Pliant Therapeutics SEC Filings

DateFilerForm TypeView
04/10/2025
3:30 PM
Pliant Therapeutics (Filer)
Form PRE 14A
03/13/2025
7:49 AM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
7:05 AM
Pliant Therapeutics (Filer)
Form 8-A12B
03/10/2025
4:24 PM
Pliant Therapeutics (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13D
03/07/2025
9:01 AM
FMR LLC (Filed by)
Pliant Therapeutics (Subject)
Form SCHEDULE 13G/A
03/03/2025
3:18 PM
Pliant Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/14/2025
7:01 PM
Pliant Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SCHEDULE 13G/A
02/13/2025
8:00 AM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
6:01 AM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
5:14 PM
Cheung Lily (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
5:01 PM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
5:04 PM
Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
5:07 PM
Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
5:10 PM
Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
4:58 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
4:55 PM
Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
4:58 PM
Cheung Lily (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:00 PM
Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:02 PM
Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:05 PM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:07 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
3:23 PM
Ouimette Mike (Reporting)
Pliant Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
8:00 PM
Pliant Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G
11/12/2024
10:53 AM
Laurion Capital Management LP (Filed by)
Pliant Therapeutics (Subject)
Form SC 13G/A
10/04/2024
4:34 PM
Paradigm Biocapital Advisors LP (Filed by)
Pliant Therapeutics (Subject)
Form SC 13G
09/27/2024
3:11 PM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
3:13 PM
Pliant Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/15/2024
10:54 AM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
5:37 PM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
5:41 PM
Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
5:45 PM
Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
5:15 PM
Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
5:22 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
4:01 PM
Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:47 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:54 PM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:41 PM
Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:15 PM
Curnutte John T (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:15 PM
Bruhn Suzanne Louise (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:15 PM
CROWELL GAYLE A (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:15 PM
Cline Darren S (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Warning: “DOGE Collapse” imminent (Ad)

Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.

Click here to see what they’re predicting now.
06/17/2024
7:15 PM
Pliant Therapeutics (Issuer)
Shah Smital (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:16 PM
Pliant Therapeutics (Issuer)
PYOTT DAVID E I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:16 PM
Huh Hoyoung (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:16 PM
Knobil Katharine (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:16 PM
MCCOURT Thomas A (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:57 PM
Krognes Steve E. (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:52 PM
Krognes Steve E. (Reporting)
Pliant Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/14/2024
6:43 AM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
3:27 PM
Pliant Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2024
5:02 AM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:PLRX) was last updated on 4/17/2025 by MarketBeat.com Staff
From Our Partners